NCT03203317 is a NA clinical trial of Insulin in Exercise, sponsored by University of Copenhagen.

Who is sponsoring NCT03203317?

NCT03203317 is sponsored by University of Copenhagen.

What drugs are being tested in NCT03203317?

Interventions in NCT03203317: Insulin, Exercise.

What condition does NCT03203317 study?

NCT03203317 studies Exercise, Insulin Sensitivity.

Is NCT03203317 still recruiting?

NCT03203317 is currently completed. Last updated 1 August 2017.

Last reviewed 2017-08-01 · How we verify

NCT03203317

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Myocellular Signalling in Skeletal Muscle

Completed NA Last updated 1 August 2017

What this trial tests

NA trial testing Insulin in Exercise in 8 participants. Completed in 26 July 2017.

Timeline

1 May 2017

Primary endpoint
26 July 2017

26 July 2017

Quick facts

Lead sponsor	University of Copenhagen
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	basic science
Enrollment	8
Start date	1 May 2017
Primary completion	26 July 2017
Estimated completion	26 July 2017
Sites	1 location across Denmark

Drugs / interventions tested

Insulin (insulin) — full drug profile →
Exercise

Conditions studied

Exercise — all drugs for Exercise →
Insulin Sensitivity — all drugs for Insulin Sensitivity →

Sponsor

University of Copenhagen

Who can join

Adults 18 to 35, male only, with Exercise or Insulin Sensitivity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will investigate myocellular signalling in skeletal muscle after insulin-stimulation and exercise in healthy young men

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Insulin

Trials testing the same drug.

NCT07460336 — Effects of Cofrogliptin on Beta-Cell Function in LADA Patients · NA · not yet recruiting
NCT07259564 — A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD) · Phase 2 · not yet recruiting
NCT06762314 — Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes · Phase 2 · recruiting
NCT06781775 — GDM: Insulin with or Without Metformin? · Phase 4 · recruiting
NCT06391853 — Investigating Brain Insulin Resistance in Alzheimer Disease with IntraNasal Insulin : a Multimodal Neuroimaging Study · NA · withdrawn

Other recruiting trials for Exercise

Currently open trials in the same condition.

NCT07504068 — Effects of Physical Exercise and a Nutritional Supplement on Body Composition, Metabolic Function, and Overall Health in · NA · recruiting
NCT07479940 — Obesity and Aging: Impacts of Nutritional Counseling and Physical Exercise on Telomeres and Senescence Parameters · NA · active not recruiting
NCT07498530 — Virtual Assistant for Exercise Adherence in Older ADULTS · NA · recruiting
NCT07426172 — Role of Elevated Lactate Levels on Lipid and Carbohydrate Metabolism. · NA · recruiting
NCT07276477 — Inspiratory Muscle Training After Stroke · NA · recruiting

Other University of Copenhagen trials

Trials by the same sponsor.

NCT07461324 — Surgeons' Prediction of Dental Surgery Complications and the Influence of Patient Characteristics: Development of an AI · not yet recruiting
NCT07389421 — School Meals in Denmark · NA · not yet recruiting
NCT07450690 — Exercise Training Effects on Muscle Function in Adults With Mitochondrial Myopathy · NA · recruiting
NCT07302880 — The Acute Interference of Biotin in Blood Analysis · NA · not yet recruiting
NCT07312981 — The CPH-MBD Cohort Dietary Substudy - Comparison of Methods for Dietary Registrations · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03203317 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Copenhagen
Last refreshed: 1 August 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03203317.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing